Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 4Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Dermatologic 1

Conditions

Lymphoma 53Lymphoma, Non-Hodgkin 36Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Follicular 28Lymphoma, Mantle-Cell 26Glioblastoma 25Central Nervous System Neoplasms 25Hodgkin Disease 22Gliosarcoma 21Astrocytoma 21Lymphoma, Large-Cell, Immunoblastic 20Brain Neoplasms 20Burkitt Lymphoma 18Leukemia, Lymphocytic, Chronic, B-Cell 17Multiple Myeloma 15Glioma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Oligodendroglioma 12Lymphoma, B-Cell, Marginal Zone 11Leukemia 10Neoplasms, Plasma Cell 9Recurrence 7Lymphoma, B-Cell 5Waldenstrom Macroglobulinemia 4Medulloblastoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, T-Cell 4Leukemia, Myeloid, Acute 4Ependymoma 4Lymphoma, Large-Cell, Anaplastic 3

Interventions

romidepsin 12Cyclophosphamide 11Vincristine 9Rituximab 9Etoposide 9Lenalidomide 8Doxorubicin 8Brentuximab Vedotin 8fludarabine 6Prednisone 6Peripheral Blood Stem Cell Transplantation 6Melphalan 6Depsipeptides 6fludarabine phosphate 5Mycophenolic Acid 5Lactones 5Gemcitabine 5Cytarabine 5Bendamustine Hydrochloride 5Antilymphocyte Serum 5Whole-Body Irradiation 4Tacrolimus 4Sirolimus 4Methotrexate 4MLN 8237 4Carmustine 4Bortezomib 410-propargyl-10-deazaaminopterin 4thymoglobulin 3duvelisib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Lymphoma, T-Cell × Carmustine × Clear all
NCT01908777 2025-10-09

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
47 enrolled
Lymphoid

Lymphoma, T-Cell

NCT02342782 2025-03-20

Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma

City of Hope Medical Center

Phase 1 Completed
20 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous

NCT01921387 2020-08-04

Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

Fred Hutchinson Cancer Center

Phase 1/2 Completed
20 enrolled 12 charts
Lymphoid

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

NCT00992446 2020-03-18

Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Fred Hutchinson Cancer Center

Phase 2 Completed
27 enrolled 13 charts
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡